Monday, July 30, 2012

Medifocus, Inc. Obtains Newly Allowed Patent and an Extensive Intellectual Property Portfolio as Part of the Recently Announced Asset Purchase With Boston Scientific Covering Prolieve(R) for the

...continued
  

URL: http://www.investorpoint.com/news/INTHPINK/53121684/

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)